论文部分内容阅读
目的:观察甲基强的松龙注射液联合硫酸镁注射液治疗重症支气管哮喘的临床疗效。方法:选取本院收治的重症支气管哮喘患者92例作为样本,将其随机分为联合组与对照组。对照组单独给予甲基强的松龙注射液治疗,联合组采用甲基强的松龙注射液联合硫酸镁注射液治疗。结果:治疗后,联合组患者FVC(3.60±0.41)L、FEV1(3.42±0.10)L、PEF(2.62±0.99)L/S、治疗有效率97.83%、生活质量评分(96.38±1.59)分,与对照组相比,优势显著(p<0.05)。结论:采用甲基强的松龙注射液联合硫酸镁注射液治疗重症支气管哮喘,临床疗效显著。
Objective: To observe the clinical efficacy of methylprednisolone injection and magnesium sulfate injection in the treatment of severe bronchial asthma. Methods: Ninety-two patients with severe bronchial asthma admitted to our hospital were selected as samples and randomly divided into the combined group and the control group. The control group was treated with methylprednisolone injection alone, and the combination group was treated with methylprednisolone injection and magnesium sulfate injection. Results: After treatment, FVC (3.60 ± 0.41) L, FEV1 (3.42 ± 0.10) L and PEF (2.62 ± 0.99) L / S in treatment group were 97.83% and 96.38 ± 1.59 respectively, Compared with the control group, the advantage was significant (p <0.05). Conclusion: Methylprednisolone injection and magnesium sulfate injection are effective in treating severe bronchial asthma.